Relmada Therapeutics, Inc. SEC filings RLMD

Relmada Therapeutics, Inc. has 606 filings in SEC EDGAR's recent list, going back to Nov 13, 2012. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 19, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021
10-K Annual report Mar 24, 2021 Dec 31, 2020
10-KT Transition report Mar 26, 2020 Dec 31, 2019
10-K Annual report Sep 24, 2019 Jun 30, 2019
10-K Annual report Sep 28, 2018 Jun 30, 2018
10-K Annual report Sep 28, 2017 Jun 30, 2017
10-K Annual report Sep 9, 2016 Jun 30, 2016
10-K Annual report Sep 11, 2015 Jun 30, 2015
10-KT Transition report Sep 9, 2014 Jun 30, 2014
10-K Annual report Dec 16, 2013 Aug 31, 2013

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RLMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Coral Gables, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1553643
Former names
CAMP NINE, INC. (until Jul 14, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.